NutraLife BioSciences (NLBS) 10-Q 17 Dec 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Sep. 30, 2015shares
Document and Entity Information:
Entity Registrant Name	NUTRAFUELS INC
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Entity Central Index Key	1,563,463
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding	22,917,114
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	No
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	ntfl

NutraFuels, Inc. - Condensed Ba

NutraFuels, Inc. - Condensed Balance Sheets - USD ($)		Sep. 30, 2015	Dec. 31, 2014
Current Assets:
Cash		$ 21,886	$ 25,053
Accounts receivable, net		33,162	1,679
Inventory, net		112,292	70,000
Prepaid expenses		1,828,689	0
TOTAL CURRENT ASSETS		1,996,029	96,732
Property, Plant and Equipment, net	[1]	240,509	248,963
Total Assets		2,236,538	345,965
Current Liabilities:
Accounts payable		41,194	34,010
Accrued liabilities		351,276	236,280
Convertible debt	[2]	791,411	617,840
Convertible debt, related party		210,000	210,000
Notes payable	[3]	55,000	46,894
Notes payable, related party		462,500	150,000
Derivative Liability		275,000
Liability of stock to be issued		107,900
Total Current Liabilities		2,294,281	$ 1,295,024
Long Term Liabilities
Convertible Debt	[2],[4]	63,184
Total Long Term Liabilities		63,184
Total Liabilities		$ 2,357,465	$ 1,295,024
Shareholders' Deficit
Preferred stock	[5]
Common stock	[6]	$ 2,292	$ 2,228
Additional paid-in capital		6,516,483	3,904,936
Accumulated Deficit		(6,639,702)	(4,856,493)
TOTAL SHAREHOLDERS' DEFICIT		(120,927)	(949,329)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT		$ 2,236,538	$ 345,695
[1]	net of accumulated depreciation of $139,862 and $98,534, respectively.
[2]	net of discount of $83,590 and $162,160
[3]	net of discount of $0 and $8,106
[4]	net of discount of of $211,816 and $0
[5]	$0.0001 par value; Authorized 10,000; issued and outstanding 1,000 and 1,000, respectively.
[6]	$0.0001 par value; Authorized 499,990,000; issued and outstanding 22,917,114 and 22,282,114, respectively.

Statement of Financial Position

Statement of Financial Position - Parenthetical - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000	10,000
Preferred Stock, Shares Issued	1,000	1,000
Preferred Stock, Shares Outstanding	1,000	1,000
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	499,990,000	499,990,000
Common Stock, Shares Issued	22,917,114	22,282,114
Common Stock, Shares Outstanding	22,917,114	22,282,114

NutraFuels, Inc. - Condensed St

NutraFuels, Inc. - Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement
Revenue	$ 47,018	$ 5,337	$ 123,328	$ 53,247
Cost of revenues	36,761	88,332	105,705	144,098
Gross Profit (loss)	10,257	(82,995)	17,623	(90,851)
Operating Expenses:
Advertising and promotion	15,720	72,612	197,016	263,859
Administrative salaries	98,403	48,500	186,344	132,500
General and administrative	575,379	180,022	1,031,426	542,144
Depreciation expense	14,479	13,135	41,327	39,307
TOTAL OPERATING EXPENSES	703,981	314,269	1,456,113	977,810
Other Income (Expense):
Income from indebtedness				7,956
Interest Income		1		15
Interest Expense	(86,380)	(102,621)	(344,718)	(256,641)
Loss Before Income Taxes	$ (780,104)	$ (499,884)	$ (1,783,208)	$ (1,317,331)
Income taxes
Net Loss	$ (780,104)	$ (499,884)	$ (1,783,208)	$ (1,317,331)
Net loss per common share- basic and diluted	$ (0.03)	$ (0.02)	$ (0.08)	$ (0.06)
Weighted average common shares outstanding- basic and diluted	22,917,714	21,857,865	22,644,210	21,593,151

NutraFuels, Inc. - Condensed S5

NutraFuels, Inc. - Condensed Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating Activities:
Net Loss	$ (780,104)	$ (499,884)	$ (1,783,208)	$ (1,317,331)	$ (1,783,208)	$ (1,317,331)
Adjustments to reconcile net loss to net cash used in operations:
Stock Compensation			615,822	29,314
Depreciation			41,327	39,307
Amortization of Debt Discount			244,861	191,427
Reclassification of down payment for equipment				(22,400)
Income from indebtedness				(7,956)		7,956
Changes in operating assets and liabilities:
Accounts receivable, increase decrease			(31,483)	(2,435)
Subscription receivable, increase decrease				25,000
Inventory, increase decrease			(42,292)	810
Accrued expenses, increase decrease			114,996	62,787
Accounts payable, increase decrease			7,185	(74,999)
Net Cash Used In Operating Activities			(832,792)	(1,076,476)
Investing Activities:
Purchase of fixed assets			(32,875)	(4,724)
Net cash used in Investing Activities			(32,875)	(4,724)
Financing Activities:
Common stock issued for cash			180,000	650,000
Proceeds from issuance of debt			370,000	420,000
Proceeds from issuance of debt- related party			312,500
Repayments of debt- related party				(25,000)
Net Cash Provided by Financing Activities			862,500	1,045,000
Net Cash decrease for the Period			(3,167)	36,200
Cash, beginning of period	$ 21,886	$ 27,055	25,053	63,255	$ 25,053	$ 63,255
Cash, end of period			$ 21,886	$ 27,055
Supplemental Disclosure of Cash Flow Information:
Income taxes
Interest
Noncash investing and financing activities:
Debt discount from beneficial conversion feature			$ 370,000	$ 43,822
Shares issued for the issuance of debt				52,778
Warrants issued for the issuance of debt				$ 290,000

Note 1 - Description of Busines

Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Notes
Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies	NOTE 1 – DESCRIPTION OF BUSINESS, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business NutraFuels, Inc. (“We”, or the “Company”) is the producer and distributor of nutritional supplements that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption. Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and the footnotes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission. Certain reclassifications have been made to the comparative period condensed financial statements in order to conform to the current period classifications.

Note 2 - Going Concern

Note 2 - Going Concern	9 Months Ended
	Sep. 30, 2015
Notes
Note 2 - Going Concern	NOTE 2 – GOING CONCERN These accompanying condensed financial statements have been prepared assuming that we will continue as a going concern. As shown in the accompanying condensed financial statements, we have sustained losses from inception, including a net loss of approximately $ 1,800,000 for the nine month period ended September 30, 2015, and we have working capital and accumulated deficits that raise substantial doubt about our ability to continue as a going concern. In response to these conditions, we seek to raise additional capital through the sale of debt or equity securities, or through borrowings from financial institutions or individuals. The condensed financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern.

Note 3 - Convertible Debt & Not

Note 3 - Convertible Debt & Notes Payable	9 Months Ended
	Sep. 30, 2015
Notes
Note 3 - Convertible Debt & Notes Payable	NOTE 3 – CONVERTIBLE DEBT & NOTES PAYABLE In February 2015, we sold 25,000 units to an investor in exchange for $ 25,000 . The 25,000 units consist of: (i) 25,000 shares of our common stock; (ii) 2-year options to purchase 25,000 shares of our common stock at $0.20, and (iii) a 2-year convertible promissory note in the amount of $25,000. The note is non-interest bearing and is convertible into shares of our common stock at the higher of (a) twenty five cents ($.25) or (b) fifty percent (50%) of the average closing price of our shares as reported by the OTC Markets for the 10 trading days prior to the day of conversion. The conversion rights embedded in the note are accounted for as a derivative financial instrument because of the beneficial conversion feature embedded therein. The beneficial conversion feature was valued and recorded at the date of issuance at fair value, and recorded as a debt discount. The proceeds received were allocated first to the derivative liability, with the residual allocated between the shares and options issued based on their relative fair values, as follows: Residual value of shares $ 0 Residual fair value of options $ 0 Fair value of BCF (derivative) $ 25,000 The note was recorded net of a full discount in the amount of $25,000, which is being amortized over the initial term of the note. At September 30, 2015, the unamortized balance of the debt discount is $ 17,295 . In April 2015, we sold 250,000 units to an investor in exchange for $ 250,000 . The 250,000 units consist of: (i) 250,000 shares of our common stock; (ii) 2-year options to purchase 250,000 shares of our common stock at $0.20, and (iii) a 2-year convertible promissory note in the amount of $250,000. The note bears 10% interest and is convertible into shares of our common stock at the higher of (a) twenty five cents ($.25) or (b) fifty percent (50%) of the average closing price of our shares as reported by the OTC Markets for the 10 trading days prior to the day of conversion. The conversion rights embedded in the note are accounted for as a derivative financial instrument because of the beneficial conversion feature embedded therein. The beneficial conversion feature was valued and recorded at the date of issuance at fair value, and recorded as a debt discount. The proceeds received were allocated first to the derivative liability, with the residual allocated between the shares and options issued based on their relative fair values, as follows: Residual value of shares $ 0 Residual fair value of options $ 0 Fair value of BCF (derivative) $ 250,000 The note was recorded net of a full discount in the amount of $250,000, which is being amortized over the initial term of the note. As of September 30, 2015, the unamortized balance of the debt discount is $194,521. In August 2015, we entered into convertible promissory notes with four individual investors for a total amount of $ 95,000 . The notes are interest bearing at a fixed rate of ten percent ( 10 %) and are convertible into shares at $ 0.10 per share. The notes were recorded net of a full discount in the amount of $95,000, which is being amortized over the initial term of the note. Each note has a term of one (1) year. At September 30, 2015, the unamortized balance of the debt discount for the four (4) promissory notes total $83,590. In August 2015, we extended the maturity of our $ 100,000 promissory note to August 26, 2016. During the third quarter of 2015, we received $ 50,000 in net proceeds from related party loans. Scheduled Debt Principal Maturities Scheduled principal maturities for debt issuances at September 30, 2015 is as follows: Year ended December 31, 2015 $ 210,000 Year ended December 31, 2016 930,000 Year ended December 31, 2017 275,000 Total 1,415,000 Less Unamortized Debt Discount (295,406) Plus General Operating Loans 462,500 Balance as of September 30, 2015 $ 1,582,094

Note 4 - Shareholders' Equity

Note 4 - Shareholders' Equity	9 Months Ended
	Sep. 30, 2015
Notes
Note 4 - Shareholders' Equity	NOTE 4 – SHAREHOLDERS’ EQUITY During February 2015, we issued 25,000 shares of our common stock and warrants to purchase 25,000 shares of our common stock in connection with the sale of 25,000 units. (see Note 3). During March 2015, we issued 60,000 shares of our common stock for consulting services rendered to us. We valued these shares at $ 1.94 per share, the closing stock price on the date of issuance. During April 2015, we issued 100,000 shares of our common stock for consulting services rendered to us. We value these shares at $ 0.51 per share, the closing stock price on the date of issuance. During April 2015, we issued 250,000 shares of our common stock and warrants to purchase 250,000 shares of our common stock in connection with the sale of 250,000 units (see Note 3). During June 2015, we issued 200,000 shares of our common stock and warrants to purchase 200,000 shares of our common stock in connection with the sale of 200,000 units. During August 2015, we received $40,000 in exchange for 400,000 shares of our common stock and warrants to purchase 400,000 shares of our common stock in connection with the sale of 400,000 units. The 400,000 shares were issued in October 2015 and the $40,000 received has been recorded under Liabilities for Stock to be issued under the Liabilities section of the Balance Sheet. During September 2015, we received $30,000 in exchange for 300,000 shares of our common stock and warrants to purchase 300,000 shares of our common stock in connection with the sale of 300,000 units. The 300,000 shares were issued in October 2015 and the $30,000 received has been recorded under Liabilities for Stock to be issued under the Liabilities section of the Balance Sheet. On July 18, 2015, we entered into a consulting agreement with WT Consulting Group, LLC. For consulting services rendered, we will pay a $ 2,000 per month retainer for services as well as 25,000 restricted shares per month. The above compensation for consulting services under this agreement will begin July 18, 2015. In July 2015, we entered into an amendment to our agreement with Sullivan Media Group, Inc., a Nevada Corporation (“SMG”). In connection with the amendment, we agree to issue warrants to acquire approximately 4,500,000 shares of our common stock, which were issued in August 2015. In connection to the above agreement we recorded a prepaid expense of $ 2,239,211 . Based on the services rendered from November 1, 2014 to September 30, 2015 we recognized stock compensation expense of $ 410,522 . The prepaid expense balance as of September 30, 2015 is $1,828,689. We determined the fair value of the warrants using a Black Scholes option pricing model with the following inputs: Risk-free interest rate 73 % Dividend yield - % Volatility factor 145 % Expected life (years) 2 The volatility was determined by referring to the average historical volatility of a peer group of public companies because we do not have a trading history from which to determine historical volatility. The risk free interest rate was determined as of September 30, 2015 through the Federal Reserve System historical data of daily interest rates. On August 1, 2015, we entered into a consulting agreement with Peter Cianci. In consideration for future consulting services, we agreed to issue shares of its common stock in exchange for services rendered on a deal by deal basis. Thirty thousand common shares were issued to Peter Cianci on October 1, 2015. In connection to the services rendered and shares issued we recognized stock compensation expense and a Liability for Stock to be issued. On August 1, 2015, we entered into a consulting agreement with Five Star Labs, LLC. In consideration for future consulting services, we agreed to issue restricted shares on a deal by deal basis. This compensation is deemded fully earned at such time as Five Star Labs, LLC provides its services. The shares were issued on October 1, 2015. In connection to the services rendered and shares issued we recognized stock compensation expense and a Liability for Stock to be issued.

Note 5 - Commitments & Continge

Note 5 - Commitments & Contingencies	9 Months Ended
	Sep. 30, 2015
Notes
Note 5 - Commitments & Contingencies	NOTE 5 – COMMITMENTS & CONTINGENCIES During January 2014, we were granted a license to market nutritional supplements under the TapouT XT name to retail locations worldwide. Under the license agreement, we were required to pay a royalty fee to Nutra Evolution of 12.5% of net sales. The agreement provided us with an initial test period of four years, until January 31, 2018, to distribute the product. We paid $ 85,000 in conjunction with the license. At the expiration of this four year period, we had the option to extend the license for three (3) consecutive three (3) year terms. The agreement originally required us to pay minimum royalties of $ 400,000 during the first contract year; $ 750,000 during the second contract year and $ 1,000,000 each year thereafter. Subsequent to March 31 2015, we terminated the license agreement and no longer are obligated to pay the minimum royalties. In late April 2014, we entered into an agreement with Sullivan Media Group, a Nevada corporation, to conduct market research in promotion of our NutraFuels brand. Through the second quarter of 2015 we have paid Sullivan Media Group a total of $ 155,000 to begin Phase 2 of our agreement, which will finalize the rebranding, repackaging, and re-launch of our NutraFuels product line. In February 2015, we entered into an agreement with GenCap Securities, LLC (“GenCap”), to serve as our exclusive placement agent, on a best efforts basis, in connection with a proposed securities offering of up to $ 10,000,000 . The agreement terminates upon the earlier of: (i) 90 days after execution, or (ii) consummation of an offering. After 90 days, this agreement may be terminated by either party upon 15 days notice. We are obligated to pay to GenCap: (i) a monthly retainer fee in the amount of $ 15,000 , payable upon a financing facilitated by GenCap; and (ii) a placement fee ranging from 5.5% to 12.0 % of the funds raised, based on the type of security sold. To date, GenCap has not secured funding for us, and no payments have been made. On April 14, 2015, we entered into a consulting agreement with Benchmark Advisory Partners, LLC. In consideration for future consulting services, we agreed to pay a fixed fee of three hundred thousand restricted shares of our stock, payable in one hundred thousand share installments on April 14, 2015, June 14, 2015, and August 14, 2015. We paid the initial installment. The agreement was terminated in June 2015. On August 1, 2015, we entered into a consulting agreement with Peter Cianci. In consideration for future consulting services, we agreed to issue shares of its common stock in exchange for services rendered. Thirty thousand common shares were issued to Peter Cianci on October 1, 2015. On August 1, 2015, we entered into a consulting agreement with Five Star Labs, LLC. In consideration for future consulting services, we agreed to issue restricted shares on a deal by deal basis. This compensation is deemed fully earned at such time as Five Star Labs, LLC provides its services. The shares were issued on October 1, 2015. On October 1, 2015, we entered into a consulting agreement with Osprey Capital Advisors. For consideration for the advisory and consulting services rendered, we agreed to pay 2,000,000 restricted shares of stock with piggyback registration rights. One Million (1,000,000) shares will be issued upon execution of the agreement and One Million shares (1,000,000) are due Sixty (60) days thereafter. In addition to the shares, $50,000 cash is due, $25,000 due on October 1, 2015 and $25,000 payable 30 days after October 1, 2015.

Note 6 - Subsequent Events

Note 6 - Subsequent Events	9 Months Ended
	Sep. 30, 2015
Notes
Note 6 - Subsequent Events	NOTE 6 – SUBSEQUENT EVENTS On August 1, 2015, we entered into a consulting agreement with Peter Cianci. In consideration for future consulting services, we agreed to issue shares of its common stock in exchange for services rendered. Thirty thousand restricted common shares were issued to Peter Cianci on October 1, 2015. On August 1, 2015, we entered into a consulting agreement with Five Star Labs, LLC. In consideration for future consulting services, we agreed to issue restricted shares on a deal by deal basis. This compensation is deemed fully earned at such time as Five Star Labs, LLC provides its services. The shares were issued on October 1, 2015. On October 1, 2015, we entered into a consulting agreement with Osprey Capital Advisors. For consideration for the advisory and consulting services rendered, we agreed to pay 2,000,000 restricted shares of stock with piggyback registration rights. One Million (1,000,000) shares will be issued upon execution of the agreement and One Million shares (1,000,000) are due Sixty (60) days thereafter. In addition to the shares, $ 50,000 cash is due, $25,000 due on October 1, 2015 and $25,000 payable 30 days after October 1, 2015. On October 13, 2015, we received $ 10,000 in exchange for 100,000 shares of our common stock and warrants to purchase 100,000 shares of our common stock in connection with the sale of 100,000 units. On October 19, 2015, we received $ 50,000 in exchange for 500,000 shares of our common stock and warrants to purchase 500,000 shares of our common stock in connection with the sale of 500,000 units. On October 22, 2015, we received $ 10,000 in exchange for 100,000 shares of our common stock and warrants to purchase 100,000 shares of our common stock in connection with the sale of 100,000 units. On October 22, 2015, we received $ 10,200 in exchange for 102,000 shares of our common stock and warrants to purchase 102,000 shares of our common stock in connection with the sale of 102,000 units. On October 22, 2015, we received $ 5,000 in exchange for 50,000 shares of our common stock and warrants to purchase 50,000 shares of our common stock in connection with the sale of 50,000 units. On November 2, 2015, we entered into stock warrant purchase agreement for 50,000 shares. On November 2, 2015, we entered into stock warrant purchase agreement for 10,000 shares. On November 2, 2015, we entered into stock warrant purchase agreement for 5,000 shares. On November 13, 2015, we received $ 10,000 in exchange for 100,000 shares of our common stock and warrants to purchase 100,000 shares of our common stock in connection with the sale of 100,000 units. On November 17, 2015, we received $ 10,000 in exchange for 100,000 shares of our common stock and warrants to purchase 100,000 shares of our common stock in connection with the sale of 100,000 units. On November 17, 2015, we entered into a cashless stock warrant purchase agreement for 15,000 shares. On November 17, 2015, we received $ 5,000 in exchange for 50,000 shares of our common stock and warrants to purchase 50,000 shares of our common stock in connection with the sale of 50,000 units. On November 25, 2015, we received $ 20,000 in exchange for 200,000 shares of our common stock and warrants to purchase 200,000 shares of our common stock in connection with the sale of 200,000 units. On November 19, 2015, we received $ 25,000 in exchange for 250,000 shares of our common stock and warrants to purchase 250,000 shares of our common stock in connection with the sale of 250,000 units. On December 7, 2015, we received $ 5,000 in exchange for 50,000 shares of our common stock and warrants to purchase 50,000 shares of our common stock in connection with the sale of 50,000 units. On December 10, 2015, we received $ 15,000 in exchange for 150,000 shares of our common stock and warrants to purchase 150,000 shares of our common stock in connection with the sale of 150,000 units. During December 2015, we received $ 25,000 in exchange for 250,000 shares of our common stock and warrants to purchase 250,000 shares of our common stock in connection with the sale of 250,000 units.

Note 1 - Description of Busin12

Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2015
Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and the footnotes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission. Certain reclassifications have been made to the comparative period condensed financial statements in order to conform to the current period classifications.

Note 3 - Convertible Debt & N13

Note 3 - Convertible Debt & Notes Payable: Schedule of Fair Value Warrants Table Text Block (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Fair Value Warrants Table Text Block	Residual value of shares $ 0 Residual fair value of options $ 0 Fair value of BCF (derivative) $ 25,000

Note 3 - Convertible Debt & N14

Note 3 - Convertible Debt & Notes Payable: Schedule of Shares and Options Issued Table Text Block (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Shares and Options Issued Table Text Block	Residual value of shares $ 0 Residual fair value of options $ 0 Fair value of BCF (derivative) $ 250,000

Note 3 - Convertible Debt & N15

Note 3 - Convertible Debt & Notes Payable: Schedule of Principal Maturities Table Text Block (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Principal Maturities Table Text Block	Year ended December 31, 2015 $ 210,000 Year ended December 31, 2016 930,000 Year ended December 31, 2017 275,000 Total 1,415,000 Less Unamortized Debt Discount (295,406) Plus General Operating Loans 462,500 Balance as of September 30, 2015 $ 1,582,094

Note 4 - Shareholders' Equity_

Note 4 - Shareholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Stockholders' Equity Note, Warrants or Rights	Risk-free interest rate 73 % Dividend yield - % Volatility factor 145 % Expected life (years) 2

Note 2 - Going Concern (Details

Note 2 - Going Concern (Details)	9 Months Ended
	Sep. 30, 2015USD ($)
Details
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 1,800,000

Note 3 - Convertible Debt & N18

Note 3 - Convertible Debt & Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Aug. 26, 2016	Aug. 31, 2015	Apr. 30, 2015	Feb. 28, 2015
Details
Convertible Notes Payable		$ 100,000	$ 95,000	$ 250,000	$ 25,000
Debt Instrument, Unamortized Discount (Premium), Net	$ 17,295
Short-term Debt, Percentage Bearing Fixed Interest Rate	73.00%		10.00%
Sale of Stock, Price Per Share			$ 0.10
Proceeds from Loans	$ 50,000

Note 3 - Convertible Debt & N19

Note 3 - Convertible Debt & Notes Payable: Schedule of Fair Value Warrants Table Text Block (Details) - NotesCommonStockAndWarrantsMember	9 Months Ended
	Sep. 30, 2015USD ($)
Relative Fair Value of Shares	$ 0
Residual Value of Warrants	0
Fair Value of Conversion Feature	$ 25,000

Note 3 - Convertible Debt & N20

Note 3 - Convertible Debt & Notes Payable: Schedule of Shares and Options Issued Table Text Block (Details) - Shares and Options Issued	9 Months Ended
	Sep. 30, 2015USD ($)
Relative Fair Value of Shares	$ 0
Residual Value of Warrants	0
Fair Value of Conversion Feature	$ 250,000

Note 3 - Convertible Debt & N21

Note 3 - Convertible Debt & Notes Payable: Schedule of Principal Maturities Table Text Block (Details) - USD ($)		Sep. 30, 2015	Dec. 31, 2014
Convertible Debt	[1],[2]	$ 63,184
Debt Instrument, Unamortized Discount		(295,406)
Other Loans Payable		462,500
2015 (6 Months)
Convertible Debt		210,000
2,016
Convertible Debt		930,000
2,017
Convertible Debt		275,000
Total
Convertible Debt		1,415,000
Balance, June 30, 2015
Convertible Debt		$ 1,582,094
[1]	net of discount of $83,590 and $162,160
[2]	net of discount of of $211,816 and $0

Note 4 - Shareholders' Equity (

Note 4 - Shareholders' Equity (Details) - USD ($)	1 Months Ended				11 Months Ended
	Aug. 31, 2015	Jun. 30, 2015	Apr. 30, 2015	Mar. 31, 2015	Sep. 30, 2015	Jul. 18, 2015	Mar. 30, 2015	Feb. 28, 2015	Dec. 31, 2014
Common Stock, Shares Issued					22,917,114				22,282,114
Common Stock, Par Value					$ 0.0001				$ 0.0001
Retainage Deposit						$ 2,000
Prepaid Expense, Current					$ 2,239,211
Share-based Compensation					$ 410,522
February 2,015
Common Stock, Shares Issued								25,000
March 2,015
Shares issued for services, Shares				60,000
Common Stock, Par Value							$ 1.94
April 2,015
Shares issued for services, Shares			100,000
Common Stock, Par Value			$ 0.51
April 2015 (2)
Shares issued for services, Shares			250,000
June 2,015
Shares issued for services, Shares		200,000
August 2,015
Shares issued for services, Shares	400,000
September 2,015
Shares issued for services, Shares	300,000

Note 4 - Shareholders' Equity23

Note 4 - Shareholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	9 Months Ended
	Sep. 30, 2015	Aug. 31, 2015
Details
Short-term Debt, Percentage Bearing Fixed Interest Rate	73.00%	10.00%
Fair Value Assumptions, Expected Volatility Rate	145.00%
Expected Life	2

Note 5 - Commitments & Contin24

Note 5 - Commitments & Contingencies (Details) - USD ($)	1 Months Ended		3 Months Ended			9 Months Ended		12 Months Ended
	Feb. 28, 2015	Jan. 31, 2014	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Jul. 18, 2015
License Costs		$ 85,000
Advertising and promotion			$ 15,720		$ 72,612	$ 197,016	$ 263,859
Retainage Deposit									$ 2,000
First Contract Year
Payments for Royalties								$ 400,000
Second Contract Year
Payments for Royalties								750,000
Each Contract Year Thereafter
Payments for Royalties								$ 1,000,000
Sullivan Media Group
Advertising and promotion				$ 155,000
GenCap
Noninterest Expense Offering Cost	$ 10,000,000
Retainage Deposit	$ 15,000
Placement Fee	12.00%

Note 6 - Subsequent Events (Det

Note 6 - Subsequent Events (Details) - USD ($)

Dec. 15, 2015

Dec. 10, 2015

Dec. 07, 2015

Nov. 25, 2015

Nov. 19, 2015

Nov. 17, 2015

Nov. 13, 2015

Nov. 02, 2015

Oct. 22, 2015

Oct. 19, 2015

Oct. 13, 2015

Oct. 01, 2015

Sep. 30, 2015

Dec. 31, 2014

Cash

$ 21,886

$ 25,053

Osprey Capital Advisors

Shares, Issued

2,000,000

Cash

$ 50,000

October 13, 2015

Shares, Issued

100,000

Cash

$ 10,000

Warrants Issued

100,000

October 19, 2015

Shares, Issued

500,000

Cash

$ 50,000

Warrants Issued

500,000

October 22, 2015

Shares, Issued

100,000

Cash

$ 10,000

Warrants Issued

100,000

October 22, 2015 (2)

Shares, Issued

102,000

Cash

$ 10,200

Warrants Issued

102,000

October 22, 2015 (3)

Shares, Issued

50,000

Cash

$ 5,000

Warrants Issued

50,000

November 2, 2015

Warrants Issued

50,000

November 2, 2015 (2)

Warrants Issued

10,000

November 2, 2015 (3)

Warrants Issued

5,000

November 13, 2015

Shares, Issued

100,000

Cash

$ 10,000

Warrants Issued

100,000

November 17, 2015

Shares, Issued

100,000

Cash

$ 10,000

Warrants Issued

100,000

November 17, 2015 (2)

Warrants Issued

15,000

November 17, 2015 (3)

Shares, Issued

50,000

Cash

$ 5,000

Warrants Issued

50,000

November 25, 2015

Shares, Issued

200,000

Cash

$ 20,000

Warrants Issued

200,000

November 19, 2015

Shares, Issued

250,000

Cash

$ 25,000

Warrants Issued

250,000

December 7, 2015

Shares, Issued

50,000

Cash

$ 5,000

Warrants Issued

50,000

December 10, 2015

Shares, Issued

150,000

Cash

$ 15,000

Warrants Issued

150,000

December 2,015

Shares, Issued

250,000

Cash

$ 25,000

Warrants Issued

250,000